Patents by Inventor Nancy Smyth-Templeton

Nancy Smyth-Templeton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7288266
    Abstract: Highly efficient cationic liposomes have been developed as an improved delivery system for biologically-active reagents. A novel structure, the sandwich liposome, is formed and comprises one or more biologically active agents internalized between two bilomellar liposomes. This structure protects the incoming agent and accounts for the high efficiency of in vivo delivery and for the broad tissue distribution of the sandwich liposome complexes. These novel liposomes are also highly efficient carriers of nucleic acids. By using extruded DOTAP:cholesterol liposomes to form complexes with DNA encoding specific proteins, expression has been improved dramatically. Highest expression was achieved in the lung, while increased expression was detected in several organs and tissues.
    Type: Grant
    Filed: February 21, 2006
    Date of Patent: October 30, 2007
    Assignee: United States of America as represented by the Secretary, Department of Health and Human Services
    Inventors: Nancy Smyth-Templeton, George N. Pavlakis
  • Publication number: 20060204566
    Abstract: Highly efficient cationic liposomes have been developed as an improved delivery system for biologically-active reagents. A novel structure, the sandwich liposome, is formed and comprises one or more biologically active agents internalized between two bilomellar liposomes. This structure protects the incoming agent and accounts for the high efficiency of in vivo delivery and for the broad tissue distribution of the sandwich liposome complexes. These novel liposomes are also highly efficient carriers of nucleic acids. By using extruded DOTAP:cholesterol liposomes to form complexes with DNA encoding specific proteins, expression has been improved dramatically. Highest expression was achieved in the lung, while increased expression was detected in several organs and tissues.
    Type: Application
    Filed: February 21, 2006
    Publication date: September 14, 2006
    Applicant: Government of the US, as represented by the Secretary, Deprtment of Health and Human Services
    Inventors: Nancy Smyth-Templeton, George Pavlakis
  • Patent number: 7037520
    Abstract: The present invention is a composition and process for avoiding non-specific uptake of targeted liposomal complexes in the lung and other highly vascular issues. The reversible masking of liposomal complexes allows increased delivery of nucleic acid molecules to target cells or tissues.
    Type: Grant
    Filed: March 20, 2003
    Date of Patent: May 2, 2006
    Assignee: Baylor College of Medicine
    Inventor: Nancy Smyth Templeton
  • Patent number: 7001614
    Abstract: Highly efficient cationic liposomes have been developed as an improved delivery system for biologically-active reagents. A novel structure, the sandwich liposome, is formed and comprises one or more biologically active agents internalized between two bilomellar liposomes. This structure protects the incoming agent and accounts for the high efficiency of in vivo delivery and for the broad tissue distribution of the sandwich liposome complexes. These novel liposomes are also highly efficient carriers of nucleic acids. By using extruded DOTAP:cholesterol liposomes to form complexes with DNA encoding specific proteins, expression has been improved dramatically. Highest expression was achieved in the lung, while increased expression was detected in several organs and tissues.
    Type: Grant
    Filed: April 15, 2004
    Date of Patent: February 21, 2006
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Nancy Smyth-Templeton, George N. Pavlakis
  • Publication number: 20040197393
    Abstract: Highly efficient cationic liposomes have been developed as an improved delivery system for biologically-active reagents. A novel structure, the sandwich liposome, is formed and comprises one or more biologically active agents internalized between two bilomellar liposomes. This structure protects the incoming agent and accounts for the high efficiency of in vivo delivery and for the broad tissue distribution of the sandwich liposome complexes.
    Type: Application
    Filed: April 15, 2004
    Publication date: October 7, 2004
    Inventors: Nancy Smyth-Templeton, George N. Pavlakis
  • Patent number: 6770291
    Abstract: Highly efficient cationic liposomes have been developed as an improved delivery system for biologically-active reagents. A novel structure, the sandwich liposome, is formed and comprises one or more biologically active agents internalized between two bilomellar liposomes. This structure protects the incoming agent and accounts for the high efficiency of in vivo delivery and for the broad tissue distribution of the sandwich liposome complexes. These novel liposomes are also highly efficient carriers of nucleic acids. By using extruded DOTAP:cholesterol liposomes to form complexes with DNA encoding specific proteins, expression has been improved dramatically. Highest expression was achieved in the lung, while increased expression was detected in several organs and tissues.
    Type: Grant
    Filed: November 20, 2001
    Date of Patent: August 3, 2004
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Nancy Smyth-Templeton, George N. Pavlakis
  • Publication number: 20030215858
    Abstract: The present disclosure provides an enhanced gene transcription system including a systematic method of selecting efficient promoter-enhancers, of optimizing plasmid design and increasing transcription of a cDNA of interest in transfected target cells. The present invention identifies abundantly, selectively expressed genes and creates plasmids comprising the promoters-enhancers of those genes.
    Type: Application
    Filed: April 3, 2003
    Publication date: November 20, 2003
    Applicant: BAYLOR COLLEGE OF MEDICINE
    Inventor: Nancy Smyth Templeton
  • Publication number: 20030180950
    Abstract: The present invention is a composition and process for avoiding non-specific uptake of targeted liposomal complexes in the lung and other highly vascular issues. The reversible masking of liposomal complexes allows increased delivery of nucleic acid molecules to target cells or tissues.
    Type: Application
    Filed: March 20, 2003
    Publication date: September 25, 2003
    Applicant: BAYLOR COLLEGE OF MEDICINE
    Inventor: Nancy Smyth Templeton
  • Publication number: 20020122819
    Abstract: Highly efficient cationic liposomes have been developed as an improved delivery system for biologically-active reagents. A novel structure, the sandwich liposome, is formed and comprises one or more biologically active agents internalized between two bilomellar liposomes. This structure protects the incoming agent and accounts for the high efficiency of in vivo delivery and for the broad tissue distribution of the sandwich liposome complexes.
    Type: Application
    Filed: November 20, 2001
    Publication date: September 5, 2002
    Inventors: Nancy Smyth-Templeton, George N. Pavlakis
  • Patent number: 6413544
    Abstract: Highly efficient cationic liposomes have been developed as an improved delivery system for biologically active reagents. A novel structure, the sandwich liposome, is formed and comprises one or more biologically active agents sandwiched (and thus sequestered) between the lipid bilayers. This structure protects the incoming agent and accounts for the high efficiency of in vivo delivery and for the broad tissue distribution of the sandwich liposome complexes. These novel liposomes are also highly efficient carriers of nucleic acids. By using extruded DOTAP:cholesterol liposomes to form complexes with DNA encoding specific proteins, expression has been improved dramatically. Highest expression was achieved in the lung, while increased expression was detected in several organs and tissues.
    Type: Grant
    Filed: October 4, 1999
    Date of Patent: July 2, 2002
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Nancy Smyth-Templeton, George N. Pavlakis
  • Publication number: 20020028219
    Abstract: Highly efficient cationic liposomes have been developed as an improved delivery system for biologicallyactive reagents. A novel structure, the sandwich liposome, is formed and comprises one or more biologically active agents internalized between two bilomellar liposomes. This structure protects the incoming agent and accounts for the high efficiency of in vivo delivery and for the broad tissue distribution of the sandwich liposome complexes. These novel liposomes are also highly efficient carriers of nucleic acids. By using extruded DOTAP:cholesterol liposomes to form complexes with DNA encoding specific proteins, expression has been improved dramatically. Highest expression was achieved in the lung, while increased expression was detected in several organs and tissues.
    Type: Application
    Filed: October 4, 1999
    Publication date: March 7, 2002
    Inventors: NANCY SMYTH-TEMPLETON, GEORGE N. PAVLAKIS